⏳ Fetching live dividend data...
Home › Calculator › MDNA Dividend Calculator 2026
Medicenna Therapeutics Corp. · NASDAQ
Price: $0.16 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in MDNA → $2396099932.58M in 10 years · $185,141,394,883,706.10/month
Medicenna Therapeutics Corp. is an immunotherapy company dedicated to discovering and commercializing innovative Superkines and "empowered Superkines" for the treatment of various cancers and other ailments. The company's primary therapeutic candidate, MDNA55 (an interleukin-4 (IL-4) EC), has successfully completed a Phase IIb clinical trial for recurrent glioblastoma. This product is also in earlier preclinical and clinical development stages for other brain and non-brain tumors. Medicenna's pipeline also features several other promising compounds: MDNA11: An enhanced version of IL-2, engineered to activate and proliferate the immune cells essential for fighting cancer. MDNA209: An IL-2 antagonist aimed at treating autoimmune conditions such as multiple sclerosis and graft-versus-host disease. MDNA413: A dual IL-4/IL-13 antagonist being developed for cancer immunotherapies. MDNA132: An IL-13 Superkine currently in development for solid tumors. Additionally, the company utilizes its proprietary BiSKITs platform, an advanced technology designed to create custom Superkines by fusing them with other proteins, antibodies, cytokines, or Superkines. Medicenna Therapeutics Corp. is headquartered in Toronto, Canada.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open MDNA position with:
Real after-tax yield depends on where you live and how you hold MDNA.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 1273.89% | 1271.09% | $127,389 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 1082.81% | 1080.01% | $108,281 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 1019.11% | 1016.31% | $101,911 / yr |
| 🇬🇧 UK ISA | 0% | 1273.89% | 1271.09% | $127,389 / yr |
| 🇬🇧 UK Taxable | 8.75% | 1162.42% | 1159.62% | $116,242 / yr |
| 🇨🇦 TFSA | 0% | 1273.89% | 1271.09% | $127,389 / yr |
| 🇨🇦 CA Taxable | 25% | 955.42% | 952.62% | $95,542 / yr |
| 🇦🇺 Super (pension) | 15% | 1082.81% | 1080.01% | $108,281 / yr |
| 🇦🇺 AU Taxable | 30% | 891.72% | 888.92% | $89,172 / yr |
| 🇩🇪 DE Taxable | 26.375% | 937.90% | 935.10% | $93,790 / yr |
| 🇫🇷 FR Taxable | 30% | 891.72% | 888.92% | $89,172 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
MDNA pays quarterly — 4 times per year. Next ex-div: TBD.
How MDNA compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for MDNA sourced from FMP /financial-growth endpoint — real data, not estimates.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the MDNA dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Medicenna Therapeutics Corp. (MDNA) is currently trading at $0.16, trading near its 52-week low. The current dividend yield is 1273.89% based on an annual payout of $2.00 per share.
Medicenna Therapeutics Corp. (MDNA) is a healthcare stock currently trading at $0.16 with a dividend yield of 1273.89%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only — not financial advice.
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →